...
jspr-img

Jasper Therapeutics Inc, Common Stock

JSPR

NAQ

$21.4

+$0.8

(3.88%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$309.03M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
44.85K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.20
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.4 L
$31.01 H
$21.4

About Jasper Therapeutics Inc, Common Stock

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameJSPRSectorS&P500
1-Week Return-8.36%-2.28%-0.57%
1-Month Return-9.65%-3.98%1.2%
3-Month Return-9.45%-9.71%7.56%
6-Month Return-15.37%-3.39%11.44%
1-Year Return385.85%3.69%28.47%
3-Year Return-77.66%3.78%29.51%
5-Year Return-79.02%39.76%90.64%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--6.20M13.51M-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":45.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-21.00K566.00K1.31M1.11M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.6,"profit":true},{"date":"2021-12-31","value":43.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.58,"profit":true}]
Gross Profit-(21.00K)(566.00K)(1.31M)(1.11M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2100000,"profit":false},{"date":"2021-12-31","value":-56600000,"profit":false},{"date":"2022-12-31","value":-131000000,"profit":false},{"date":"2023-12-31","value":-110800000,"profit":false}]
Gross Margin--(9.13%)(9.70%)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9.13,"profit":false},{"date":"2022-12-31","value":-9.7,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses4.45M20.68M36.83M51.20M68.86M[{"date":"2019-12-31","value":6.47,"profit":true},{"date":"2020-12-31","value":30.04,"profit":true},{"date":"2021-12-31","value":53.49,"profit":true},{"date":"2022-12-31","value":74.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(4.71M)(20.68M)(36.83M)(51.20M)(68.86M)[{"date":"2019-12-31","value":-471000000,"profit":false},{"date":"2020-12-31","value":-2068300000,"profit":false},{"date":"2021-12-31","value":-3683300000,"profit":false},{"date":"2022-12-31","value":-5119600000,"profit":false},{"date":"2023-12-31","value":-6886100000,"profit":false}]
Total Non-Operating Income/Expense---14.21M7.97M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":56.06,"profit":true}]
Pre-Tax Income(4.99M)(31.67M)(30.64M)(37.69M)(66.09M)[{"date":"2019-12-31","value":-498700000,"profit":false},{"date":"2020-12-31","value":-3166900000,"profit":false},{"date":"2021-12-31","value":-3063700000,"profit":false},{"date":"2022-12-31","value":-3768500000,"profit":false},{"date":"2023-12-31","value":-6609300000,"profit":false}]
Income Taxes(277.00)(38.45K)(6.65M)(13.51M)(1.63M)[{"date":"2019-12-31","value":-27700,"profit":false},{"date":"2020-12-31","value":-3845100,"profit":false},{"date":"2021-12-31","value":-665300000,"profit":false},{"date":"2022-12-31","value":-1351100000,"profit":false},{"date":"2023-12-31","value":-162800000,"profit":false}]
Income After Taxes---(24.17M)(64.47M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-2417400000,"profit":false},{"date":"2023-12-31","value":-6446500000,"profit":false}]
Income From Continuous Operations-(6.48M)(36.83M)(51.20M)(64.47M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-648070100,"profit":false},{"date":"2021-12-31","value":-3683300000,"profit":false},{"date":"2022-12-31","value":-5119600000,"profit":false},{"date":"2023-12-31","value":-6446500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.99M)(31.67M)(23.98M)(24.17M)(64.47M)[{"date":"2019-12-31","value":-498700000,"profit":false},{"date":"2020-12-31","value":-3166900000,"profit":false},{"date":"2021-12-31","value":-2398400000,"profit":false},{"date":"2022-12-31","value":-2417400000,"profit":false},{"date":"2023-12-31","value":-6446500000,"profit":false}]
EPS (Diluted)(0.00)0.06(2.35)(1.03)(1.97)[{"date":"2019-12-31","value":-0.17,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-3916.67,"profit":false},{"date":"2022-12-31","value":-1716.67,"profit":false},{"date":"2023-12-31","value":-3283.33,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

JSPR
Cash Ratio 7.42
Current Ratio 7.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

JSPR
ROA (LTM) -40.92%
ROE (LTM) -71.46%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

JSPR
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

JSPR
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.69
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Jasper Therapeutics Inc share price today?

Jasper Therapeutics Inc (JSPR) share price today is $21.4

Can Indians buy Jasper Therapeutics Inc shares?

Yes, Indians can buy shares of Jasper Therapeutics Inc (JSPR) on Vested. To buy Jasper Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in JSPR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Jasper Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Jasper Therapeutics Inc (JSPR) via the Vested app. You can start investing in Jasper Therapeutics Inc (JSPR) with a minimum investment of $1.

How to invest in Jasper Therapeutics Inc shares from India?

You can invest in shares of Jasper Therapeutics Inc (JSPR) via Vested in three simple steps:

  • Click on Sign Up or Invest in JSPR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Jasper Therapeutics Inc shares
What is Jasper Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Jasper Therapeutics Inc (JSPR) is $31.01. The 52-week low price of Jasper Therapeutics Inc (JSPR) is $4.4.

What is Jasper Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Jasper Therapeutics Inc (JSPR) is

What is Jasper Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Jasper Therapeutics Inc (JSPR) is 3.69

What is Jasper Therapeutics Inc dividend yield?

The dividend yield of Jasper Therapeutics Inc (JSPR) is 0.00%

What is the Market Cap of Jasper Therapeutics Inc?

The market capitalization of Jasper Therapeutics Inc (JSPR) is $309.03M

What is Jasper Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Jasper Therapeutics Inc is JSPR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top